Cargando…

Proteomic Analysis of Complement Proteins in Membranous Nephropathy

INTRODUCTION: Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in Caucasian adults. Phospholipase A2 receptor (PLA2R)– and exostosin 1 (EXT1)/exostosin 2 (EXT2)–associated MN represent the most common primary and secondary forms of MN. The complement profile using a proteom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravindran, Aishwarya, Madden, Benjamin, Charlesworth, M. Cristine, Sharma, Rishi, Sethi, Amit, Debiec, Hanna, Cattran, Daniel, Fervenza, Fernando C., Smith, Richard J., Ronco, Pierre, Sethi, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210748/ https://www.ncbi.nlm.nih.gov/pubmed/32405583 http://dx.doi.org/10.1016/j.ekir.2020.01.018

Ejemplares similares

Advances in Membranous Nephropathy
por: Ronco, Pierre, et al.
Publicado: (2021)

Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy
por: Zubidat, Dalia, et al.
Publicado: (2023)

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy
por: Hladunewich, Michelle A., et al.
Publicado: (2014)

Membranous nephropathy: current understanding of various causes in light of new target antigens
por: Ronco, Pierre, et al.
Publicado: (2021)

Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series
por: Ravindran, Aishwarya, et al.
Publicado: (2022)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

Leishmaniasis-Associated Membranoproliferative Glomerulonephritis With Massive Complement Deposition
por: Sethi, Sanjeev, et al.
Publicado: (2016)

Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy
por: Muruve, Daniel A., et al.
Publicado: (2022)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

C3 Glomerulonephritis: Clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up
por: Sethi, Sanjeev, et al.
Publicado: (2012)

An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression
por: Zand, Ladan, et al.
Publicado: (2019)

Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
por: Dähnrich, Cornelia, et al.
Publicado: (2019)

Membranous nephropathy: a single disease or a pattern of injury resulting from different diseases
por: Sethi, Sanjeev
Publicado: (2021)

Future landscape for the management of membranous nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy
por: Sethi, Supreet, et al.
Publicado: (2020)

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
por: Berchtold, Lena, et al.
Publicado: (2017)

Atypical post-infectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Circulating antibodies to α-enolase and phospholipase A(2) receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy
por: Kimura, Yukihiro, et al.
Publicado: (2016)

Novel Treatments Paradigms: Membranous Nephropathy
por: Rojas-Rivera, Jorge E., et al.
Publicado: (2023)

C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome
por: Bobart, Shane A., et al.
Publicado: (2019)

“Precision” Medicine in Membranous Nephropathy: Serology-Guided Therapy
por: Glassock, Richard J., et al.
Publicado: (2023)

The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes
por: Saïdi, Michèle, et al.
Publicado: (2021)

The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and Membranous Nephropathy
por: Bu, Lihong, et al.
Publicado: (2023)

Antenatal Membranous Nephropathy and Type 2 (Axonal) Charcot-Marie-Tooth With Mutations in the Metallo-Membrane Endopeptidase Gene: A Call for Family Screening and Pharmacovigilance
por: Nortier, Joëlle L., et al.
Publicado: (2021)

Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosis
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
por: Hladunewich, Michelle A., et al.
Publicado: (2021)

Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
por: Pourcine, Franck, et al.
Publicado: (2017)

Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
por: Rojas-Rivera, Jorge, et al.
Publicado: (2021)

Histiocytic glomerulopathy associated with macrophage activation syndrome
por: Eirin, Alfonso, et al.
Publicado: (2015)

Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2021)

Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023)

Pathophysiological lessons from rare associations of immunological disorders
por: Ronco, Pierre, et al.
Publicado: (2009)

Pathophysiological lessons from rare associations of autoimmune diseases
por: Ronco, Pierre, et al.
Publicado: (2012)

Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients
por: Michel, Pierre-Antoine, et al.
Publicado: (2011)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults
por: Lepori, Nicola, et al.
Publicado: (2018)

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations
por: Sethi, Sanjeev, et al.
Publicado: (2014)

Renal involvement in Neimann-Pick Disease
por: Grafft, Carrie A., et al.
Publicado: (2009)

Therapeutic trials in adult FSGS: lessons learned and the road forward
por: De Vriese, An S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8bu5kdsf4n72a2jh5sr1n5bhmo